Abstract
Ankylosing spondylitis (AS) is characterised by a geographic differences in terms of prevalence and clinical expression of the disease. The aim of our study was to describe the actual features of AS in Morocco and we wanted to examine a large population of patients for evidence of phenotypic clustering that could suggest the presence of distinct clinical entities. We investigated 117 patients with a diagnosis of primary AS according to the modified New York criteria. All patients were evaluated according to a standardised data collection form, including demographic variables and disease history with clinical and radiological features. To analyse our data and try to individualise clinical subsets, we applied a two-step cluster analysis using log-likelihood distance measures. Patient’s mean age at onset was 25.51 ± 10.8 year. The mean BASDAI and BASFI score was 33.5 ± 20.3 and 38.9 ± 27.5, respectively. Radiographic damage was present in 99.1% of the subjects and radiographic hip involvement in 47.3%. Only 52.6% of patients had been treated with disease modifying antirheumatic drugs. Cluster analysis detected two distinct populations within the data set. Statistically significant differences were found between the two groups particularly concerning activity of the disease, age at onset and the hygienic conditions. Our study revealed that the Moroccan AS was active and severe and suggested that the age at onset and the precarious hygienic level has the greatest capacity to predict activity and severity of the disease.
Similar content being viewed by others
References
Creemers MC (2002) Ankylosing spondylitis: what do we really know about the onset and progression of this disease? J Rheumatol 29(6):1121–1123
Sieper J, Rudwaleit M, Khan MA, Braun J (2006) Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 20(3):401–417. doi:10.1016/j.berh.2006.02.001
Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY (1998) Features of spondyloarthritis around the world. Rheum Dis Clin North Am 24:753–770. doi:10.1016/S0889-857X(05)70040-5
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(3 Suppl):iii8–iii18
El Maghraoui A (2004) Ankylosing spondylitis. Presse Med 33(20):1459–1464. doi:10.1016/S0755-4982(04)98954-3
Will R, Edmunds L, Elswood J, Calin A (1990) Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol 17:1649–1652
van der Linden S, van der Heijde D (1998) Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am 24:663–676. doi:10.1016/S0889-857X(05)70036-3
Khan MA (1998) A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog JD (eds) The spondyloarthritides. Oxford University Press, Oxford, pp 17–26
Ng SC, Liao Z, Yu DT, Chan ES, Zhao L, Gu J (2007) Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum 37(1):39–47. doi:10.1016/j.semarthrit.2007.01.003
Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL et al (2007) Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 46(8):1309–1315. doi:10.1093/rheumatology/kem084
De Angelis R, Salaffi F, Grassi W (2007) Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol 36(1):14–21. doi:10.1080/03009740600904243
Boonen A, van der Heijde D, Landewé R, Guillemin F, Spoorenberg A, Schouten H et al (2003) Costs of ankylosing spondylitis in three European countries: the patient’s perspective. Ann Rheum Dis 62(8):741–747. doi:10.1136/ard.62.8.741
Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA (2004) Epidemiology of ankylosing spondylitis in Northwest Greece, 1983–2002. Rheumatology (Oxford) 43(5):615–618. doi:10.1093/rheumatology/keh133
Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33(2):289–295
Brown MA, Crane AM, Wordsworth BP (2002) Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis. Curr Opin Rheumatol 14(4):354–360. doi:10.1097/00002281-200207000-00004
Hajjaj-Hassouni N, Maetzel A, Dougados M, Amor B (1993) Comparison of patients evaluated for spondylarthropathy in France and Morocco. Rev Rhum Ed Fr 60(6):420–425
Claudepierre P, Gueguen A, Ladjouze A, Hajjaj Hassouni N, Sellam S, Amor B, Dougadous M (1996) Particularités des formes de debut juvenile au sein des spondylarthropathies au Maghreb. Rev Rhum Ed Fr 63(2):93–97
Claudepierre P, Gueguen A, Ladjouze A, Hajjaj-Hassouni N, Sellami S, Amor B, Dougados M (1995) Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol 34(12):1139–1145. doi:10.1093/rheumatology/34.12.1139
Zochling J, Bohl-Bühler MH, Baraliakos X, Feldtkeller E, Braun J (2006) Infection and work stress are potential triggers of ankylosing spondylitis. Clin Rheumatol 25(5):660–666. doi:10.1007/s10067-005-0131-z
Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. doi:10.1002/art.1780270401
Macrae IF, Wright V (1969) Measurement of back movement. Ann Rheum Dis 28:584–589. doi:10.1136/ard.28.6.584
Hollingsworth PN, Cheah PS, Dawkins RL, Owen ET, Calin A, Wood PH (1983) Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol 10:247–254
Bellamy N, Newhook L, Rooney PJ et al (1984) Perception—a problem in the grading of sacro-iliac joint radiographs. Scand J Rheumatol 13:113–120. doi:10.3109/03009748409100373
Bennett PH, Burch TA (1967) New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis 17:453–458
Grigoryan M, Roemer FW, Mohr A, Genant HK (2004) Imaging in spondyloarthropathies. Curr Rheumatol Rep 6(2):102–109. doi:10.1007/s11926-004-0054-8
Rostom S, Benbouazza K, Bahiri R, Lazrak N, Jroundi I, Abouqal R et al (2005) Adaptation transculturelle et validation de la version arabe marocaine dialectale du Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) dans la spondylarhtrite ankylosante (abstract). 18° congres of SFR, Paris
Rostom S, Benbouazza K, Bahiri R, Lazrak N, Jroundi I, Abouqal R et al (2005) Adaptation transculturelle et validation de la version arabe marocaine dialectale du Bath Ankylosing Spondylitis Functional Index (BASFI) dans la spondylarhtrite ankylosante (abstract). 18° congres of SFR, Paris
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Brian E, Landau S, Leese M (2001) Cluster analysis. Edward Arnold, London
Østensen M, Østensen H (1998) Ankylosing spondylitis—the female aspect. J Rheumatol 25(1):120–124
Calin A, Brophy S, Blake D (1999) Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet 354:1687–1690. doi:10.1016/S0140--6736(99)03219-5
Lee W, Reveille JD, Davis JC Jr, Learch TJ, Ward MM, Weisman MH (2007) Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 66(5):633–638. doi:10.1136/ard.2006.060293
Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O, Ergor A, Manisali M, Akkoc N (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35:305–309
Younsi R, Azrib S, Aitouazar M, Harifi G, EL Hassani S (2007) Evaluation de l’incidence du gène HLA-B27 chez le patient atteint de spondylarthrite ankylosante au Maroc. Rev Rhum 74:976–1037 (absract)
Schlosstein L, Terasaki PJ, Bluestone R, Pearson CM (1973) High association of an HLA antigen, w27, with ankylosing spondylitis. N Engl J Med 288:704–706
Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC, Sturrock RD (1973) Ankylosing spondylitis and HLA-B27. Lancet 1:904–907. doi:10.1016/S0140-6736(73)91360-3
Choi SJ, Park MH (1987) HLA-B27 frequency in Korean patients with ankylosing spondylitis. Seoul J Med 28:247–250
Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD, Song YW (2004) Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology 43:1526–1531. doi:10.1093/rheumatology/keh373
Robertson LP, Davis MJ (2004) A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology 43:1565–1568. doi:10.1093/rheumatology/keh386
Pavy S, Brophy S, Hickey S, Calin A (2002) Iritis: is it a predictor of long-term outcome in ankylosing spondylitis? Rheumatology 41(Suppl 1):A306
Smith JA, Märker-Hermann E, Colbert RA (2006) Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol 20(3):571–579. doi:10.1016/j.berh.2006.03.001
Brophy S, Calin A (2001) Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 28(10):2283–2288
Rkain H, Allali F, Bentalha A, Lazrak N, Abouqal R, Hajjaj-Hassouni N (2007) Socioeconomic impact of ankylosing spondylitis in Morocco. Clin Rheumatol 26(12):2081–2088. doi:10.1007/s10067-007-0622-1
Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD (2005) Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 53(3):445–451. doi:10.1002/art.21174
Ebringer A, Wilson C (2000) HLA molecules, bacteria and autoimmunity. J Med Microbiol 49(4):305–311
Kim TH, Uhm WS, Inman RD (2005) Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 17(4):400–405. doi:10.1097/01.bor.0000163447.44037.c4
Toussirot E, Wendling D (2006) The immunogenetics of ankylosing spondylitis. Rev Med Interne 27(10):762–771. doi:10.1016/j.revmed.2006.05.005
Brown MA (2008) Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford) 47(2):132–137. doi:10.1093/rheumatology/kem269
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mansouri, L.E., Bahiri, R., Abourazzak, F.E. et al. Two distinct patterns of ankylosing spondylitis in Moroccan patients. Rheumatol Int 29, 1423–1429 (2009). https://doi.org/10.1007/s00296-009-0873-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0873-z